• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子 21:代谢调节的“变阻器”?

Fibroblast growth factor 21: A "rheostat" for metabolic regulation?

机构信息

Department of Endocrinology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510999, China; Department of Nephrology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510999, China.

State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou 510515, China.

出版信息

Metabolism. 2022 May;130:155166. doi: 10.1016/j.metabol.2022.155166. Epub 2022 Feb 18.

DOI:10.1016/j.metabol.2022.155166
PMID:35183545
Abstract

Fibroblast growth factor 21 is an evolutionarily conserved factor that plays multiple important roles in metabolic homeostasis. During the past two decades, extensive investigations have improved our understanding of its delicate metabolic roles and identified its pharmacological potential to mitigate metabolic disorders. However, most clinical trials have failed to obtain the desired results, which raises issues regarding its clinical value. Fibroblast growth factor 21 is dynamically regulated by nutrients derived from food intake and hepatic/adipose release, which in turn act on the central nervous system, liver, and adipose tissues to influence food preference, hepatic glucose, and adipose fatty acid output. Based on this information, we propose that fibroblast growth factor 21 should not be considered merely an anti-hyperglycemia or anti-obesity factor, but rather a means of balancing of nutrient fluctuations to maintain an appropriate energy supply. Hence, the specific functions of fibroblast growth factor 21 in glycometabolism and lipometabolism depend on specific metabolic states, indicating that its pharmacological effects require further consideration.

摘要

成纤维细胞生长因子 21 是一种进化上保守的因子,在代谢稳态中发挥多种重要作用。在过去的二十年中,广泛的研究提高了我们对其微妙代谢作用的理解,并确定了其药理学潜力,以减轻代谢紊乱。然而,大多数临床试验未能获得预期的结果,这引发了关于其临床价值的问题。成纤维细胞生长因子 21 受到来自食物摄入和肝脏/脂肪释放的营养素的动态调节,这些营养素反过来作用于中枢神经系统、肝脏和脂肪组织,影响食物偏好、肝脏葡萄糖和脂肪组织脂肪酸的输出。基于这些信息,我们提出成纤维细胞生长因子 21 不应仅仅被视为抗高血糖或抗肥胖因子,而是一种平衡营养波动以维持适当能量供应的手段。因此,成纤维细胞生长因子 21 在糖代谢和脂代谢中的特定功能取决于特定的代谢状态,表明其药理学作用需要进一步考虑。

相似文献

1
Fibroblast growth factor 21: A "rheostat" for metabolic regulation?成纤维细胞生长因子 21:代谢调节的“变阻器”?
Metabolism. 2022 May;130:155166. doi: 10.1016/j.metabol.2022.155166. Epub 2022 Feb 18.
2
Potential roles of fibroblast growth factor 21 in the brain.成纤维细胞生长因子21在大脑中的潜在作用。
Metab Brain Dis. 2016 Apr;31(2):239-48. doi: 10.1007/s11011-015-9789-3. Epub 2016 Jan 6.
3
Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.成纤维细胞生长因子 21:代谢稳态的多功能调节剂。
Annu Rev Nutr. 2018 Aug 21;38:173-196. doi: 10.1146/annurev-nutr-071816-064800. Epub 2018 May 4.
4
Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.肝小泛素相关修饰蛋白酶 2 通过 SUMOylation 依赖的肝脂肪组织串扰调控来控制全身代谢。
Hepatology. 2021 Oct;74(4):1864-1883. doi: 10.1002/hep.31881. Epub 2021 Sep 9.
5
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.柚皮素可预防雄性小鼠肥胖、肝脂肪变性和葡萄糖不耐受,且不依赖成纤维细胞生长因子21。
Endocrinology. 2015 Jun;156(6):2087-102. doi: 10.1210/en.2014-2003. Epub 2015 Mar 16.
6
Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.成纤维细胞生长因子21的营养调控:从常量营养素到生物活性膳食化合物
Horm Mol Biol Clin Investig. 2016 Sep 1;30(1):/j/hmbci.2017.30.issue-1/hmbci-2016-0034/hmbci-2016-0034.xml. doi: 10.1515/hmbci-2016-0034.
7
Understanding the Physiology of FGF21.了解成纤维细胞生长因子21的生理学
Annu Rev Physiol. 2016;78:223-41. doi: 10.1146/annurev-physiol-021115-105339. Epub 2015 Nov 19.
8
Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.成纤维细胞生长因子 21 与营养挑战的适应性反应。
Int J Mol Sci. 2019 Sep 21;20(19):4692. doi: 10.3390/ijms20194692.
9
FGF21 in obesity and cancer: New insights.肥胖与癌症中的成纤维细胞生长因子21:新见解
Cancer Lett. 2021 Feb 28;499:5-13. doi: 10.1016/j.canlet.2020.11.026. Epub 2020 Nov 29.
10
The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.成纤维细胞生长因子21在脂质代谢和高血压中的潜在作用
Curr Hypertens Rep. 2017 Apr;19(4):28. doi: 10.1007/s11906-017-0730-5.

引用本文的文献

1
Integrative analysis reveals novel inflammatory and metabolic pathways in glioblastoma development: A large-scale mediation Mendelian randomization study.综合分析揭示胶质母细胞瘤发生过程中的新型炎症和代谢途径:一项大规模中介孟德尔随机化研究
Medicine (Baltimore). 2025 Aug 1;104(31):e43636. doi: 10.1097/MD.0000000000043636.
2
Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study.循环成纤维细胞生长因子21与中国人群血压相关:一项基于社区的研究。
Ann Med. 2025 Dec;57(1):2500689. doi: 10.1080/07853890.2025.2500689. Epub 2025 May 12.
3
Increased FGF-21 Improves Ectopic Lipid Deposition in the Liver and Skeletal Muscle.
成纤维细胞生长因子 21 增加可改善肝脏和骨骼肌的异位脂质沉积。
Nutrients. 2024 Apr 23;16(9):1254. doi: 10.3390/nu16091254.
4
Roles of fibroblast growth factors in the treatment of diabetes.成纤维细胞生长因子在糖尿病治疗中的作用。
World J Diabetes. 2024 Mar 15;15(3):392-402. doi: 10.4239/wjd.v15.i3.392.
5
mTORC1 in energy expenditure: consequences for obesity.能量消耗中的mTORC1:对肥胖的影响。
Nat Rev Endocrinol. 2024 Apr;20(4):239-251. doi: 10.1038/s41574-023-00934-0. Epub 2024 Jan 15.
6
Bo's abdominal acupuncture improves disordered metabolism in obese type 2 diabetic rats through regulating fibroblast growth factor 21 and its related adipokines.Bo 氏腹针通过调节成纤维细胞生长因子 21 及其相关脂肪因子改善肥胖 2 型糖尿病大鼠的代谢紊乱。
J Tradit Chin Med. 2023 Oct;43(6):1200-1208. doi: 10.19852/j.cnki.jtcm.20231008.002.
7
Hepatocellular carcinoma induced by hepatocyte Pten deletion reduces BAT UCP-1 and thermogenic capacity in mice, despite increasing serum FGF-21 and iWAT browning.肝细胞 Pten 缺失诱导的肝细胞癌减少了小鼠 BAT UCP-1 和产热能力,尽管血清 FGF-21 和 iWAT 棕色化增加。
J Physiol Biochem. 2023 Nov;79(4):731-743. doi: 10.1007/s13105-023-00970-4. Epub 2023 Jul 5.
8
A Short-Term High-Fat Diet Worsens Insulin Sensitivity with Changes in Metabolic Parameters in Non-Obese Japanese Men.短期高脂饮食会使非肥胖日本男性的胰岛素敏感性恶化,并伴有代谢参数的变化。
J Clin Med. 2023 Jun 16;12(12):4084. doi: 10.3390/jcm12124084.
9
Fibroblast growth factor 21 (FGF21) attenuates tacrolimus-induced hepatic lipid accumulation through transcription factor EB (TFEB)-regulated lipophagy.成纤维细胞生长因子 21(FGF21)通过转录因子 EB(TFEB)调节的脂噬作用减轻他克莫司诱导的肝脂质蓄积。
J Zhejiang Univ Sci B. 2023 Jun 15;24(6):485-495. doi: 10.1631/jzus.B2200562.
10
Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021.2000年至2021年期间成纤维细胞生长因子21研究的文献计量分析。
Front Pharmacol. 2022 Sep 27;13:1011008. doi: 10.3389/fphar.2022.1011008. eCollection 2022.